Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Moderna Inc (MRNA)

Moderna Inc (MRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 15,157,980
  • Shares Outstanding, K 384,818
  • Annual Sales, $ 6,848 M
  • Annual Income, $ -4,714 M
  • EBIT $ -2,693 M
  • EBITDA $ -2,133 M
  • 60-Month Beta 1.58
  • Price/Sales 2.22
  • Price/Cash Flow N/A
  • Price/Book 1.27

Options Overview Details

View History
  • Implied Volatility 81.47% ( -4.83%)
  • Historical Volatility 73.32%
  • IV Percentile 94%
  • IV Rank 77.94%
  • IV High 92.67% on 12/18/24
  • IV Low 41.88% on 05/17/24
  • Put/Call Vol Ratio 1.87
  • Today's Volume 75,470
  • Volume Avg (30-Day) 94,412
  • Put/Call OI Ratio 0.77
  • Today's Open Interest 732,971
  • Open Int (30-Day) 676,432

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 25 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -3.00
  • Number of Estimates 12
  • High Estimate -1.90
  • Low Estimate -4.05
  • Prior Year 0.55
  • Growth Rate Est. (year over year) -645.45%

Price Performance

See More
Period Period Low Period High Performance
1-Month
35.96 +9.54%
on 11/21/24
47.41 -16.92%
on 12/09/24
+2.45 (+6.63%)
since 11/20/24
3-Month
35.80 +10.03%
on 11/15/24
67.96 -42.04%
on 09/30/24
-26.30 (-40.04%)
since 09/20/24
52-Week
35.80 +10.03%
on 11/15/24
170.47 -76.89%
on 05/24/24
-46.80 (-54.30%)
since 12/20/23

Most Recent Stories

More News
Is Moderna Stock a Buy?

Moderna 's (NASDAQ: MRNA) wild success in the COVID-19 vaccine market has worn off. The company's revenue, earnings, and stock price have been moving in the wrong direction for the past three years, a...

MRNA : 39.39 (-0.43%)
3 Stocks That Could Turn $1,000 into $5,000 by 2030

A five-bagger in only five years? Any investor would love to buy such a stock. Fortunes can be made quickly with those kinds of turbocharged performers.

GOOGL : 191.41 (+1.54%)
GOOG : 192.96 (+1.72%)
TSLA : 421.06 (-3.46%)
MRK : 98.05 (-1.48%)
SMMT : 17.87 (-2.88%)
WRD : 14.70 (-2.46%)
MRNA : 39.39 (-0.43%)
UBER : 60.73 (+0.86%)
Stock Market News for Dec 18, 2024

Wall Street closed lower on Tuesday, eagerly awaiting the Fed meeting. Market participants showed restraint in trading ahead of the Fed's last policy announcement of 2024 after economic data released on...

AVGO : 220.79 (+1.13%)
MRNA : 39.39 (-0.43%)
3 No-Brainer Biotech Stocks to Buy With $200 Right Now

Investing in biotech stocks usually isn't for the faint of heart. These stocks tend to be highly volatile because of the inherent risks of developing new drugs.

SMMT : 17.87 (-2.88%)
MRNA : 39.39 (-0.43%)
BNTX : 113.08 (+1.56%)
Stock market today: Wall Street trims its stellar gains as Nvidia's star dims again

U.S. stock indexes trimmed some of their stellar gains for the year

MSTR : 364.20 (+11.56%)
NVDA : 134.70 (+3.08%)
AVGO : 220.79 (+1.13%)
BAC : 44.17 (+1.82%)
$SPX : 5,930.85 (+1.09%)
MS : 123.44 (+2.44%)
JNJ : 144.47 (+0.62%)
$IUXX : 21,289.15 (+0.85%)
PFE : 26.36 (+2.29%)
BMY : 57.33 (+1.83%)
BAX : 29.50 (+2.08%)
$DOWI : 42,840.26 (+1.18%)
Is Moderna Stock Underperforming the Dow?

Moderna has significantly underperformed the Dow over the past year, and analysts are cautious about the stock’s prospects.

$DOWI : 42,840.26 (+1.18%)
MRNA : 39.39 (-0.43%)
PFE : 26.36 (+2.29%)
Why I Can't Stop Buying This Ultra-High-Yielding ETF

I love generating passive income. I currently use that income to make more income-generating investments. My goal is to eventually make enough income from passive sources to cover my routine living expenses....

MSFT : 436.60 (-0.10%)
QQQ : 518.66 (+0.87%)
NVDA : 134.70 (+3.08%)
AAPL : 254.49 (+1.88%)
TSLA : 421.06 (-3.46%)
AVGO : 220.79 (+1.13%)
JPM : 237.60 (+1.99%)
LRCX : 71.79 (+0.81%)
ORCL : 169.66 (+0.52%)
MRNA : 39.39 (-0.43%)
JEPQ : 57.20 (+0.70%)
AMZN : 224.92 (+0.73%)
Palantir Stock Is Joining the Nasdaq-100 Index, and Super Micro Computer Is Being Booted: What Investors Should Know

Palantir stock's huge rise this year has earned it a spot on another stock index.

MSTR : 364.20 (+11.56%)
NDAQ : 77.70 (+0.41%)
SMCI : 31.59 (+1.12%)
ILMN : 136.02 (+1.51%)
AXON : 631.69 (+2.60%)
MRNA : 39.39 (-0.43%)
PLTR : 80.55 (+8.54%)
These Are the 5 Worst-Performing Stocks in the S&P 500 With 2024 Almost Over

2024 has been a generally outstanding year for the stock market, with the S&P 500 (SNPINDEX: ^GSPC) up by nearly 30% year to date as of Dec. 11. However, not all stocks have performed nearly this well...

CE : 68.25 (+1.82%)
INTC : 19.52 (+2.41%)
DLTR : 72.94 (+5.62%)
$SPX : 5,930.85 (+1.09%)
WBA : 9.55 (+2.14%)
MRNA : 39.39 (-0.43%)
GSK Stock Declines 20% in 3 Months: Should You Buy, Sell or Hold?

GSK GSK stock has declined 20.2% in the past three months compared with a decrease of 12.3% for the industry. The stock has also underperformed the sector and the S&P 500 index, as seen in the chart below....

HLN : 9.69 (-0.10%)
MRNA : 39.39 (-0.43%)
GSK : 33.60 (+0.51%)
SNY : 47.71 (+0.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Moderna, Inc. is a clinical-stage pharmaceutical company, primarily focused on discovering and developing messenger RNA (mRNA) based therapies. The company's mRNA based COVID-19 vaccine, Spikevax (mRNA-1273), is approved for use in adults in the United States. The vaccine is also authorized for emergency...

See More

Key Turning Points

3rd Resistance Point 42.15
2nd Resistance Point 41.49
1st Resistance Point 40.44
Last Price 39.39
1st Support Level 38.73
2nd Support Level 38.07
3rd Support Level 37.02

See More

52-Week High 170.47
Fibonacci 61.8% 119.03
Fibonacci 50% 103.14
Fibonacci 38.2% 87.24
Last Price 39.39
52-Week Low 35.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar